Dr Lylia Ouboussad
Academic scientist in Clinical Rheumatology and Experimental Rheumatology, investigating epigenetics, particularly microRNAs expression profiles in serum samples from clinical RA cohorts. I have obtained my PhD in cancer genetics at Brunel University (West London) in 2008. Moved to Leeds in 2009 to do a postdoctoral project in haematology (Leeds Institute of Molecular Medicine) until 2012, then joined the Institute of Rheumatic and Musculoskeletal Disease in Professor McDermott’s group (experimental rheumatology) as a postdoctoral research fellow working on the role of the unfolded protein response in the pathogenesis of RA and treatment response to biologics-based therapies and epigenetics of RA.’ From October 2013, I carried on working within LIRMM under the supervision Dr Maya Buch and Prof. McDermott on the role of epigenetics in RA.RA, UPR, epigenetics, microRNAPost-doctoral.
The role of the unfolded protein response pathway in the pathogenesis of RA and treatment response to biologics-based therapies and regulation of microRNAs in RA
Research groups and institutes
- Leeds Institute of Rheumatic and Musculoskeletal Medicine